JP Morgan Chase’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-278,500
Closed -$38.6M 6171
2020
Q3
$38.6M Buy
278,500
+192,100
+222% +$23.4M 0.01% 1109
2020
Q2
$6.5M Buy
+86,400
New +$4.52M ﹤0.01% 2257

JP Morgan Chase's LVGO Position: Q4 2020 in Review

JP Morgan Chase sold out of Livongo Health, Inc. Common Stock (LVGO) in Q4 2020, closing a stake of 138,785 shares — an estimated $19.2M sold.

JP Morgan Chase first reported a position in LVGO in Q3 2019 and held it in 5 quarters. The position peaked at $19.2M in Q3 2020. 0 funds tracked by Wall St. Rank hold LVGO as of Q4 2020.

  • JP Morgan Chase reported no remaining Livongo Health, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • JP Morgan Chase sold 138,785 Livongo Health, Inc. Common Stock shares in Q4 2020, an estimated $19.2M.
  • JP Morgan Chase first reported a position in Livongo Health, Inc. Common Stock in Q3 2019 and held it in 5 quarters.
  • JP Morgan Chase's Livongo Health, Inc. Common Stock position peaked at $19.2M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q4 2020.

Based on JP Morgan Chase's 13F filing for Q4 2020, filed 11 Feb 2021.